- Home
- BTBT vs FHTX Comparison
BTBT vs FHTX Comparison
Compare BTBT & FHTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTBT
- FHTX
- Stock Information
- Founded
- BTBT 2015
- FHTX 2015
- Country
- BTBT United States
- FHTX United States
- Employees
- BTBT N/A
- FHTX N/A
- Industry
- BTBT Finance: Consumer Services
- FHTX Medicinal Chemicals and Botanical Products
- Sector
- BTBT Finance
- FHTX Health Care
- Exchange
- BTBT Nasdaq
- FHTX Nasdaq
- Market Cap
- BTBT 437.8M
- FHTX 271.5M
- IPO Year
- BTBT 2018
- FHTX 2020
- Fundamental
- Price
- BTBT $3.29
- FHTX $5.88
- Analyst Decision
- BTBT Strong Buy
- FHTX Strong Buy
- Analyst Count
- BTBT 3
- FHTX 8
- Target Price
- BTBT $6.33
- FHTX $12.63
- AVG Volume (30 Days)
- BTBT 52.9M
- FHTX 150.1K
- Earning Date
- BTBT 08-18-2025
- FHTX 08-07-2025
- Dividend Yield
- BTBT N/A
- FHTX N/A
- EPS Growth
- BTBT N/A
- FHTX N/A
- EPS
- BTBT N/A
- FHTX N/A
- Revenue
- BTBT $102,037,923.00
- FHTX $23,504,000.00
- Revenue This Year
- BTBT $31.34
- FHTX $33.60
- Revenue Next Year
- BTBT $40.97
- FHTX $5.87
- P/E Ratio
- BTBT N/A
- FHTX N/A
- Revenue Growth
- BTBT 52.44
- FHTX N/A
- 52 Week Low
- BTBT $1.69
- FHTX $2.95
- 52 Week High
- BTBT $5.74
- FHTX $10.25
- Technical
- Relative Strength Index (RSI)
- BTBT 62.28
- FHTX 71.42
- Support Level
- BTBT $1.88
- FHTX $4.78
- Resistance Level
- BTBT $3.74
- FHTX $5.52
- Average True Range (ATR)
- BTBT 0.33
- FHTX 0.36
- MACD
- BTBT 0.09
- FHTX 0.07
- Stochastic Oscillator
- BTBT 58.26
- FHTX 83.44
About BTBT Bit Digital Inc.
Bit Digital Inc is engaged in the Bitcoin mining business, Ethereum staking activities and specialized cloud-infrastructure services for artificial intelligence applications through its wholly owned subsidiaries. Its mining platform operates with the primary intent of accumulating bitcoin which may sell for fiat currency from time to time depending on market conditions. The Company has four reportable segments: digital asset mining, cloud services, colocation services, and ETH Staking. It generates majority of its revenue from digital asset mining.
About FHTX Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate, and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.